Emerging ideas: Interleukin-12 nanocoatings prevent open fracture-associated infections

Clinical Orthopaedics and Related Research

Volumn 469, Issue 11, 2011, Pages 3262-3265

  Li, Bingyun ^a,b,c   McKeague, Anne L ^d  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WVNano Initiative   (United States)

^c West Virginia University   (United States)

^d USAF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 12P70; NANOCOATING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMUR FRACTURE; HELPER CELL; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RESISTANCE; INFECTION RISK; INTRAMEDULLARY NAILING; NONHUMAN; OPEN FRACTURE; PRIORITY JOURNAL; PROSTHESIS INFECTION; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 80054761306     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-010-1690-0     Document Type: Article

References (27)

1. MK Angele E Faist 2002 Clinical review: immunodepression in the surgical patient and increased susceptibility to infection Crit Care. 6 298 305 12225603 10.1186/cc1514
2. TM Bielecki TS Gazdzik J Arendt T Szczepanski W Król T Wielkoszynski 2007 Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study J Bone Joint Surg Br. 89 417 420 17356164 10.1302/0301-620X.89B3.18491 1:STN:280: DC%2BD2s7ls1WktA%3D%3D
3. RC Bone 1996 Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) Ann Intern Med. 125 680 687 8849154 1:STN:280:DyaK28vhs1GmsA%3D%3D
4. IB Brune W Wilke T Hensler B Holzmann JR Siewert 1999 Downregulation of T helper type 1 immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery Am J Surg. 177 55 60 10037309 10.1016/S0002-9610(98)00299-2 1:STN:280:DyaK1M7lsV2isQ%3D%3D
5. Canale ST. Campbells Operative Orthopaedics. 10th ed. St Louis, MO: Mosby-Year Book; 2003.
6. AM Cooper J Magram J Ferrante IM Orme 1997 Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis J Exp Med. 186 39 45 9206995 10.1084/jem.186.1.39 1:CAS:528:DyaK2sXksFaisr0%3D
7. AI Daud RC DeConti S Andrews P Urbas AI Riker VK Sondak PN Munster DM Sullivan KE Ugen JL Messina R Heller 2008 Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma J Clin Oncol. 26 5896 5903 19029422 10.1200/JCO.2007.13.9048 1:CAS:528:DC%2BD1MXhs1Ggurk%3D
8. G de Lissovoy K Fraeman V Hutchins D Murphy D Song BB Vaughn 2009 Surgical site infection: incidence and impact on hospital utilization and treatment costs Am J Infect Control. 37 387 397 19398246 10.1016/j.ajic.2008.12. 010
9. E Faist A Mewes T Strasser A Walz S Alkan C Baker W Ertel G Heberer 1988 Alteration of monocyte function following major injury Arch Surg. 123 287 292 3124800 1:CAS:528:DyaL1cXhsVylu7c%3D
10. MK Gately LM Renzetti J Magram AS Stern L Adorini U Gubler DH Presky 1998 The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses Annu Rev Immunol. 16 495 521 9597139 10.1146/annurev.immunol.16.1.495 1:CAS:528:DyaK1cXisl2gsbs%3D
11. A Goebel E Kavanagh A Lyons IB Saporoschetz C Soberg JA Lederer JA Mannick ML Rodrick 2000 Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection Ann Surg. 231 253 261 10674618 10.1097/00000658-200002000-00015 1:STN:280: DC%2BD3c7jslSrsQ%3D%3D
12. T Hamza JB Barnett B Li 2010 Interleukin 12 a key immunoregulatory cytokine in infection applications Int J Mol Sci. 11 789 806 20479986 10.3390/ijms11030789 1:CAS:528:DC%2BC3cXjtVKhsLw%3D
13. T Hensler H Hecker K Heeg CD Heidecke H Bartels W Barthlen H Wagner JR Siewert B Holzmann 1997 Distinct mechanisms of immunosuppression as a consequence of major surgery Infect Immun. 65 2283 2291 9169765 1:CAS:528:DyaK2sXjsFWns7w%3D
14. T Hensler CD Heidecke H Hecker K Heeg H Bartels N Zantl H Wagner JR Siewert B Holzmann 1998 Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production J Immunol. 161 2655 2659 9725269 1:CAS:528:DyaK1cXlslamtrk%3D
15. JA Lederer ML Rodrick JA Mannick 1999 The effects of injury on the adaptive immune response Shock. 11 153 159 10188766 10.1097/00024382-199903000- 00001 1:STN:280:DyaK1M3gt1Knuw%3D%3D
16. B Li B Jiang BM Boyce BA Lindsey 2009 Multilayer polypeptide nanoscale coatings incorporating IL-12 for the prevention of biomedical device-associated infections Biomaterials. 30 2552 2558 19215980 10.1016/j.biomaterials.2009.01. 042 1:CAS:528:DC%2BD1MXisVCmt70%3D
17. B Li B Jiang MJ Dietz ES Smith NB Clovis KM Rao 2010 Evaluation of local MCP-1 and IL-12 nanocoatings for infection prevention in open fractures J Orthop Res. 28 48 54 19588527 10.1002/jor.21169 1:CAS:528:DC%2BC3cXkvFOjug%3D%3D
18. DH Livingston SH Appel SR Wellhausen G Sonnenfeld HC Polk Jr 1988 Depressed interferon gamma production and monocyte HLA-DR expression after severe injury Arch Surg. 123 1309 1312 3140765 1:STN:280:DyaL1M%2FisFWntA%3D%3D
19. JA Mannick ML Rodrick JA Lederer 2001 The immunologic response to injury J Am Coll Surg. 193 237 244 11548792 10.1016/S1072-7515(01)01011-0 1:STN:280:DC%2BD3MvpvFymsg%3D%3D
20. RJ Motzer A Rakhit LH Schwartz T Olencki TM Malone K Sandstrom R Nadeau H Parmar R Bukowski 1998 Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma Clin Cancer Res. 4 1183 1191 9607576 1:CAS:528:DyaK1cXjt1yiu74%3D
21. C OSuilleabhain ST OSullivan JL Kelly J Lederer JA Mannick ML Rodrick 1996 Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury Surgery. 120 290 296 8751595 10.1016/S0039-6060(96)80300-X
22. OSullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg. 1995;222:482-490; discussion 490-492.
23. Pull ter Gunne AF, Cohen DB. Incidence, prevalence, and analysis of risk factors for surgical site infection following adult spinal surgery. Spine (Phila Pa 1976). 2009;34:1422-1428.
24. G Schmidmaier B Wildemann M Lubberstedt NP Haas M Raschke 2003 IGF-I and TGF-beta 1 incorporated in a poly(D, L-lactide) implant coating stimulates osteoblast differentiation and collagen-1 production but reduces osteoblast proliferation in cell culture J Biomed Mater Res B Appl Biomater. 65 157 162 12632385 10.1002/jbm.b.10513 1:STN:280:DC%2BD3s7hvVeqsA%3D%3D
25. B Sugarman EJ Young 1989 Infections associated with prosthetic devices: magnitude of the problem Infect Dis Clin North Am. 3 187 198 2663976 1:STN:280:DyaL1MzgvFOjtA%3D%3D
26. G Trinchieri M Wysocka A DAndrea M Rengaraju M Aste-Amezaga M Kubin NM Valiante J Chehimi 1992 Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation Prog Growth Factor Res. 4 355 368 1364096 10.1016/0955-2235(92)90016-B 1:CAS:528:DyaK2cXhtlWmsrw%3D
27. K Tsung JB Meko GR Peplinski YL Tsung JA Norton 1997 IL-12 induces T helper 1-directed antitumor response J Immunol. 158 3359 3365 9120294 1:CAS:528:DyaK2sXit1Cksb8%3D